Zobrazeno 71 - 80
of 80
pro vyhledávání: '"Nico Gagelmann"'
Publikováno v:
Blood. 134:3113-3113
Background Cellular immunotherapies represent an enormously promising strategy for relapsed/refractory multiple myeloma (RRMM). Chimeric antigen receptor (CAR) T cells targeting B cell maturation antigen (BCMA) have shown impressive results in early-
Autor:
Anja van Biezen, Linda Koster, Simona Iacobelli, Hareth Nahi, Xavier Leleu, Nico Gagelmann, Diderik-Jan Eikema, Nicolaus Kröger, Anne-Marie Stoppa, Denis Caillot, Miklós Udvardy, Charles Crawley, Maija Itälä-Remes, Tamas Masszi, Stig Lenhoff, Ann Hunter, Laurent Garderet, Pietro Pioltelli, Clara Mariette, Martin R. Schipperus, Maurizio Musso, Michel Delforge, John A. Snowden, William Arcese
Publikováno v:
Haematologica, 103(5), 890-897
Haematologica
Haematologica
We investigated extramedullary disease in newly diagnosed multiple myeloma patients and its impact on outcome following first-line autologous stem cell transplantation. We identified 3744 adult myeloma patients who received up-front single (n=3391) o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdce3b527bffa4fcd492b5399a0d913
https://hdl.handle.net/1887/79365
https://hdl.handle.net/1887/79365
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(10)
Over the past 25 years, several randomized controlled trials have investigated the efficacy of different antiviral agents for cytomegalovirus (CMV) prophylaxis in allogeneic hematopoietic cell transplantation. We performed a systematic literature rev
Autor:
Christine Wolschke, Francis Ayuk, Ute-Marie von Pein, Maximilian Gröger, Axel R. Zander, Nicolaus Kröger, Nico Gagelmann, Max Christopeit, Evgeny Klyuchnikov
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 24(7)
The major reason for treatment failure after allografting in multiple myeloma (MM) is relapse. Donor lymphocyte infusions (DLIs) are considered a valuable post-transplant strategy mainly for relapsed patients but using them to prevent relapse in MM h
Autor:
Marie Robin, Dietrich W. Beelen, Bruno Cassinat, Markus Ditschkowski, Nico Gagelmann, Rabia Shahswar, Nicolaus Kroeger, Felicitas Thol, Rashit Bogdanov, Anita Badbaran, Michael Heuser
Background The dynamic International Prognostic Scoring System (DIPSS) is commonly applied to predict survival among patients with primary myelofibrosis (PMF) but has been shown to perform less precisely in secondary myelofibrosis (SMF) and after tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cd1e86a3896cdcd830348423025c3a2
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(12)
Since 2000, various phase III randomized controlled trials (RCTs) have investigated the efficacy of rabbit antithymocyte globulin (ATG) in patients following allogeneic stem cell transplantation (allo-SCT). Comparisons of different ATG formulations a
Autor:
Linda Koster, Hareth Nahi, Simona Iacobelli, Péter Reményi, Xavier Poiré, Stig Lenhoff, Nico Gagelmann, Samo Zver, Dirk-Jan Eikema, Ibrahim Yakoub-Agha, Xavier Leleu, Nicolaus Kroeger, Alexander M Martin, Hélène Schoemans, Pietro Pioltelli, Mark Ringhoffer, Alessandro Rambaldi, Laurent Garderet, Patrice Chevallier, Stefan Schönland, Claude-Eric Bulabois, Didier Blaise, Denis Caillot, Guido Kobbe, Nicola Mordini, Urpu Salmenniemi, Jakob Passweg
Publikováno v:
Blood. 132:2143-2143
Introduction Current consensus identifies translocations t(4;14), t(14;16), t(14;20), and del(17/17p) as high-risk cytogenetics in newly diagnosed multiple myeloma (NDMM). However, evidence on outcome of specific abnormalities according to types of t
Autor:
Nicolaus Kröger, Nico Gagelmann
Publikováno v:
Advances in Cell and Gene Therapy. 1:e12
Autor:
Stig Lenhoff, Denis Caillot, Clara Mariette, Ann Hunter, Linda Koster, Simona Iacobelli, John A. Snowden, Xavier Leleu, Pietro Pioltelli, Maurizio Musso, William Arcese, Charles Crawley, Michel Delforge, Laurent Garderet, Nicolaus Kröger, Martin R. Schipperus, Nico Gagelmann, Anne-Marie Stoppa, Miklós Udvardy, Tamas Masszi, Maija Itälä-Remes, Hareth Nahi
Publikováno v:
Blood. 128:2266-2266
Introduction Multiple myeloma (MM) is characterized by a proliferation of plasma cells with a strong dependence on the bone marrow (BM) microenvironment. However, in some MM patients this proliferation escapes the BM resulting in extramedullary disea
Autor:
Gagelmann N; Nico Gagelmann, MD, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; and Maximilian Merz, MD, Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology, University Hospital of Leipzig, Leipzig, Germany., Merz M; Nico Gagelmann, MD, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; and Maximilian Merz, MD, Department of Hematology, Cellular Therapy, Hemostaseology and Infectiology, University Hospital of Leipzig, Leipzig, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 24, pp. JCO2400863. Date of Electronic Publication: 2024 Jun 24.